Peer Reviewed

1

Document Type

Article

Publication Date

6-2018

Keywords

Acquired Factor Xiii Deficiency, Bleeding.

Comments

The original article is available at www.imj.ie

Abstract

Factor XIII (FXIII) is a plasma clotting protein involved in clot stabilization. Severe FXIII deficiency may present with severe, even fatal bleeding. Critically however, routine coagulation assays may be normal and only specific FXIII assays will detect the abnormality. Herein we discuss a case report of a patient with acquired FXIII deficiency in order to highlight the clinical challenges associated with establishing the diagnosis and discuss the treatment approach. A 70-year-old man presented with a gluteal haematoma despite no preceding personal history of bleeding. Extensive initial haemostatic investigations were normal until a specific FXIII assay showed a marked reduction in FXIII levels. With directed treatment, bleeding episodes ceased and remission was achieved. Clinical awareness of FXIII deficiency is important, so appropriate testing can be implemented in patients with unexplained bleeding diatheses, particularly those in whom bleeding responds poorly to standard replacement therapy.

Disciplines

Life Sciences

Citation

H Fogarty, M Byrne, NM. O’Connell, K Ryan, B White, JS. O’Donnell, M Lavin. Acquired Factor Xiii Deficiency: An Uncommon But Easily Missed Cause Of Severe Bleeding. Irish Medical Journal. 2018;111(5)757

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.

Included in

Life Sciences Commons

Share

COinS